Results 281 to 290 of about 892,099 (304)

Immune checkpoint inhibitor diabetes mellitus: a novel form of autoimmune diabetes

Clinical and Experimental Immunology, 2020
Mark Anderson
exaly  

Cardiac myosin-specific autoimmune T cells contribute to immune-checkpoint-inhibitor-associated myocarditis

Cell Reports, 2022
Taejoon Won, Ninaad Lasrado, Daniela Čiháková   +2 more
exaly  

Immune checkpoint inhibitor-associated myopathy: a clinicoseropathologically distinct myopathy.

Brain Communications, 2020
James Triplett, Felix Diehn, Teerin Liewluck   +2 more
exaly  

Overview of checkpoint inhibitor pneumonitis: incidence and associated risk factors

Expert Opinion on Drug Safety, 2021
Shuji Murakami, Terufumi Kato
exaly  

Decreased Absolute Lymphocyte Count and Increased Neutrophil/Lymphocyte Ratio With Immune Checkpoint Inhibitor–Associated Myocarditis

Journal of the American Heart Association, 2020
Ryan J Sullivan, Zsofia Dora Drobni, Tomas G Neilan   +2 more
exaly  

Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in Large Arteries

Circulation, 2020
Marcus Hacker, Verena Pichler
exaly  

Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells

Cell, 2018
Eric Vivier, Sophie Guia, Caroline Hoffmann   +2 more
exaly  

Dose dependence of treatment-related adverse events for immune checkpoint inhibitor therapies: a model-based meta-analysis

OncoImmunology, 2020
Sergey Aksenov, Ganesh Mugundu, Kirill Peskov   +2 more
exaly  

Checkpoint inhibitors in the emergency department

Emergency Medicine Australasia, 2019
Caroline AE Bachmeier, Adam Morton
openaire   +5 more sources

Checkpoint Inhibitor–Induced Colitis

American Journal of Gastroenterology, 2020
Anusha S, Thomas, Yinghong, Wang
openaire   +2 more sources